Emai£ºmarketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
Tel: +1(781)535-1428(U.S. - West Coast)
0044 7790 816 954 (Europe)
Email: marketing@medicilon.com
µØµã£ºÉϺ£ÊÐÆÖ¶«ÐÂÇø´¨ºàáé585ºÅ
Óʱࣺ201299
µç»°£º+86 (21) 5859-1500£¨×Ü»ú£©
´«Õ棺+86 (21) 5859-6369
×èÖ¹±±¾©Ê±¼ä Êý¾ÝȪԴµÚÈý·½£¬½ö¹©²Î¿¼
ÏÖʵÐÅÏ¢Çë²Î¿¼£º¶«·½²Æ²úÍø
? 2023 ×ðÁú¿Ê± ±£´æËùÓÐȨÁ¦ »¦ICP±¸10216606ºÅ-3
»¦¹«Íø°²±¸ 31011502018888ºÅ | ÍøÕ¾µØͼ
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞ·þÎñ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
GLP-1ÔÚ²î±ð×éÖ¯ÖоßÓжàÖÖ×÷ÓúÍÆÕ±éµÄÖÎÁÆDZÁ¦¡£
GLP-1 shows numerous actions in different tissues, and a broad therapeutic potential.
GLP-1µÄÖ÷Òª×÷ÓÃÊǴ̼¤ÒȵºËØÉø͸²¢ÒÖÖÆÒȸßѪÌÇËØÉø͸£¬´Ó¶øÓÐÖúÓÚ¿ØÖƲͺóѪÌDz¨¶¯¡£
The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion,thereby contributing to limit postprandial glucose excursions.
GLP-1 ¿ÉÒÔÔöÇ¿±¥¸¹¸Ð¶øµ¼ÖÂÌåÖؼõÇᣬ±ðµÄ£¬GLP-1»¹ÒÖÖÆ賦µÀÔ˶¯ºÍÉø͸£¬¿ÉÒԳ䵱³¦Î¸Ëغ͡°»Ø³¦Öƶ¯¡±»úÖƵÄÒ»²¿·Ö¡£
GLP-1 also causes weight loss by increasing satiety. In addition, GLP-1 also inhibits gastrointestinal motility and secretion,and thus acts as an enterogastrone and part of the "ileal brake" mechanism.